Data last refreshed 45 days ago — analysis may not reflect the latest market data

Thermo Fisher Scientific Inc.TMO

NYSE • Healthcare

—

$448.50

P/E

24.62

PEG

2.56

FCF Yield

—

Rev Growth YoY

+6.2% YoY

Gross Margin

40.7%

Health Score

—

D/E Ratio

0.76

Confidence

—

Business Snapshot

Business snapshot content not available.

Financial Health

Risk Assessment

Metric deep-dives

P/E Ratio→PEG Ratio→EV/EBITDA→FCF Yield→Revenue Growth→Gross Margin→Return on Equity (ROE)→Debt-to-Equity→Current Ratio→Quick Ratio→

Last updated 1084 hours ago · Data sourced from FMP & Finnhub · Not financial advice